Quercetin is a major constituent of various dietary products, which is increasingly being investigated as a therapeutic option in the oncological field. It has attracted extensive interest due to its ability of interacting with different molecular targets and evoking a broad spectrum of chemopreventive and anticancer activities. In this review, we have tried to present and critically discuss its potential against an extensive range of cancers including lung, ovarian, prostate, breast, colorectal, bladder cancers. We also highlighted studies that combined quercetin with standard anticancer drugs and delivered it via novel techniques and included a detailed description of its proposed mechanism(s) of action, and pharmacokinetic and safety profile.

The molecular basis of the anticancer properties of quercetin / Adorisio, S.; Argentieri, M.P.; Avato, P.; Caderni, G.; Chioccioli, S.; Cirmi, S.; Delfino, D.V.; Greco, G.; Hrelia, P.; Iriti, M.; Lenzi, M.; Lombardo, G.E.; Luceri, C.; Maugeri, A.; Montopoli, M.; Muscari, I.; Nani, M.F.; Navarra, M.; Gasperini, S.; Turrini, E.; Fimognari, C.. - In: PHARMADVANCES. - ELETTRONICO. - 3:3(2021), pp. 496-520. [10.36118/pharmadvances.2021.10]

The molecular basis of the anticancer properties of quercetin

Greco, G.;Hrelia, P.;Lenzi, M.;Maugeri, A.;Gasperini, S.;Turrini, E.;Fimognari, C.
2021

Abstract

Quercetin is a major constituent of various dietary products, which is increasingly being investigated as a therapeutic option in the oncological field. It has attracted extensive interest due to its ability of interacting with different molecular targets and evoking a broad spectrum of chemopreventive and anticancer activities. In this review, we have tried to present and critically discuss its potential against an extensive range of cancers including lung, ovarian, prostate, breast, colorectal, bladder cancers. We also highlighted studies that combined quercetin with standard anticancer drugs and delivered it via novel techniques and included a detailed description of its proposed mechanism(s) of action, and pharmacokinetic and safety profile.
2021
The molecular basis of the anticancer properties of quercetin / Adorisio, S.; Argentieri, M.P.; Avato, P.; Caderni, G.; Chioccioli, S.; Cirmi, S.; Delfino, D.V.; Greco, G.; Hrelia, P.; Iriti, M.; Lenzi, M.; Lombardo, G.E.; Luceri, C.; Maugeri, A.; Montopoli, M.; Muscari, I.; Nani, M.F.; Navarra, M.; Gasperini, S.; Turrini, E.; Fimognari, C.. - In: PHARMADVANCES. - ELETTRONICO. - 3:3(2021), pp. 496-520. [10.36118/pharmadvances.2021.10]
Adorisio, S.; Argentieri, M.P.; Avato, P.; Caderni, G.; Chioccioli, S.; Cirmi, S.; Delfino, D.V.; Greco, G.; Hrelia, P.; Iriti, M.; Lenzi, M.; Lombardo, G.E.; Luceri, C.; Maugeri, A.; Montopoli, M.; Muscari, I.; Nani, M.F.; Navarra, M.; Gasperini, S.; Turrini, E.; Fimognari, C.
File in questo prodotto:
File Dimensione Formato  
THE MOLECULAR BASIS OF THE ANTICANCER PROPERTIES OF QUERCETIN.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per accesso libero gratuito
Dimensione 1.2 MB
Formato Adobe PDF
1.2 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/832549
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact